ALPN
Goldman Sachs’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-240,435
| Closed | -$9.53M | – | 4990 |
|
|
2024
Q1 | $9.53M | Buy |
240,435
+42,491
| +21% | +$1.68M | ﹤0.01% | 2077 |
|
|
2023
Q4 | $3.77M | Buy |
197,944
+131,499
| +198% | +$2.51M | ﹤0.01% | 2786 |
|
|
2023
Q3 | $761K | Buy |
66,445
+10,670
| +19% | +$122K | ﹤0.01% | 3679 |
|
|
2023
Q2 | $573K | Buy |
55,775
+24,918
| +81% | +$256K | ﹤0.01% | 3905 |
|
|
2023
Q1 | $238K | Buy |
30,857
+368
| +1% | +$2.84K | ﹤0.01% | 4448 |
|
|
2022
Q4 | $224K | Buy |
30,489
+6,550
| +27% | +$48.1K | ﹤0.01% | 4456 |
|
|
2022
Q3 | $172K | Sell |
23,939
-18,977
| -44% | -$136K | ﹤0.01% | 4768 |
|
|
2022
Q2 | $365K | Buy |
42,916
+20,066
| +88% | +$171K | ﹤0.01% | 4579 |
|
|
2022
Q1 | $205K | Buy |
22,850
+9,471
| +71% | +$85K | ﹤0.01% | 5086 |
|
|
2021
Q4 | $185K | Buy |
+13,379
| New | +$185K | ﹤0.01% | 5028 |
|
|
2021
Q2 | – | Sell |
-10,577
| Closed | -$112K | – | 5604 |
|
|
2021
Q1 | $112K | Buy |
+10,577
| New | +$112K | ﹤0.01% | 5006 |
|
|
2017
Q1 | – | Sell |
-42,130
| Closed | -$94K | – | 4574 |
|
|
2016
Q4 | $94K | Sell |
42,130
-34,893
| -45% | -$77.9K | ﹤0.01% | 4115 |
|
|
2016
Q3 | $626K | Buy |
77,023
+49,699
| +182% | +$404K | ﹤0.01% | 3304 |
|
|
2016
Q2 | $126K | Buy |
27,324
+6,657
| +32% | +$30.7K | ﹤0.01% | 4036 |
|
|
2016
Q1 | $86K | Sell |
20,667
-349,191
| -94% | -$1.45M | ﹤0.01% | 4075 |
|
|
2015
Q4 | $2.86M | Sell |
369,858
-3,312
| -0.9% | -$25.6K | ﹤0.01% | 2342 |
|
|
2015
Q3 | $4.84M | Sell |
373,170
-19,344
| -5% | -$251K | ﹤0.01% | 2036 |
|
|
2015
Q2 | $5.95M | Buy |
+392,514
| New | +$5.95M | ﹤0.01% | 1984 |
|